Gossamer Bio, Inc. (GOSS) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time GOSS price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 46.0 Neutral
Market Cap $41.1M
Volume 3.9M
Fundamentals — 10-Q Q1 2026
Revenue $17.0M
Net Income $-46.7M
EPS $-0.20
Operating Margin -264.6%
Net Margin -275.2%
P/E Ratio -0.9x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Milligan Sandra | Director | Buy | 26,050 | $1.92 | $50,016 | 2025 Aug 19 |
| Aranda Richard | Chief Medical Officer | Sell | 1,908 | $0.66 | $1,259 | 2024 Jun 24 |
| Hasnain Faheem | President & CEO | Buy | 372,000 | $0.67 | $249,240 | 2024 Jun 21 |
| Giraudo Bryan | COO/CFO | Buy | 100,000 | $0.59 | $59,000 | 2024 Jun 18 |
| Smith Robert Paul JR | Chief Commercial Officer | Buy | 25,000 | $0.60 | $15,000 | 2024 Jun 17 |
| Giraudo Bryan | COO/CFO | Sell | 6,430 | $1.16 | $7,459 | 2024 Mar 27 |
| Hasnain Faheem | President & CEO | Sell | 23,172 | $1.16 | $26,880 | 2024 Mar 27 |
| Christian Waage | EVP, Tech Ops and Admin | Sell | 6,430 | $1.16 | $7,459 | 2024 Mar 27 |
| Aranda Richard | Chief Medical Officer | Sell | 4,018 | $1.33 | $5,344 | 2024 Mar 18 |
| Peterson Caryn | EVP, Regulatory Affairs | Sell | 4,018 | $1.33 | $5,344 | 2024 Mar 18 |
| Milligan Sandra | Director | Buy | 32,000 | $0.79 | $25,280 | 2023 Nov 15 |
| Giraudo Bryan | COO/CFO | Buy | 200,000 | $0.56 | $112,000 | 2023 Nov 13 |
| Aranda Richard | Chief Medical Officer | Sell | 1,814 | $1.29 | $2,340 | 2023 Jun 22 |
| Giraudo Bryan | COO/CFO | Buy | 55,000 | $1.02 | $56,100 | 2023 Apr 4 |
| Hasnain Faheem | President & CEO | Buy | 878,572 | $1.14 | $999,180 | 2023 Mar 22 |
| Giraudo Bryan | COO/CFO | Buy | 50,000 | $0.97 | $48,500 | 2023 Mar 20 |
| Christian Waage | EVP, Tech Ops and Admin | Buy | 18,500 | $1.20 | $22,200 | 2023 Mar 20 |
| Carter Laura | Chief Scientific Officer | Sell | 6,029 | $1.10 | $6,632 | 2023 Mar 16 |
| Aranda Richard | Chief Medical Officer | Sell | 7,563 | $1.10 | $8,319 | 2023 Mar 16 |
| Peterson Caryn | EVP, Regulatory Affairs | Sell | 7,564 | $1.10 | $8,320 | 2023 Mar 16 |
Other Pharmaceutical Stocks
Take GOSS further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GOSS in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Gossamer Bio, Inc. next reports.
Set alerts on GOSS
Get notified when Gossamer Bio, Inc. hits your price targets or technical conditions are met.
Get Started Free